logo
Select company
Select metric
5.04%Inventory to Assets Ratio
VS
Market
32
Sector
28
Industry
10
History
18
$ 30.27Close
$ 13.63 - $ 41.99 52-Week Range
Ticker Information

Ticker

RIGL

Company Name

RIGEL PHARMACEUTICALS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

RIGEL PHARMACEUTICALS INC - Inventory to Assets Ratio Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

RIGL - Inv. to Assets Historical data
DateTotal AssetsInventoryInventory to Assets Ratio
6/30/2025$ 206.74M$ 10.42M5.04%
3/31/2025$ 175.97M$ 4.66M2.65%
12/31/2024$ 163.98M$ 6M3.66%
9/30/2024$ 139.42M$ 4.78M3.43%
6/30/2024$ 128.41M$ 8.06M6.28%
3/31/2024$ 126.52M$ 6.58M5.2%
12/31/2023$ 117.22M$ 5.52M4.71%
9/30/2023$ 115.32M$ 6.11M5.3%
6/30/2023$ 117.09M$ 10.78M9.21%
3/31/2023$ 123.61M$ 11.08M8.96%
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • RIGEL PHARMACEUTICALS INC's latest trailing twelve months (TTM) Inv. to Assets stands at 1.67%.
  • Over the past 5 years, RIGEL PHARMACEUTICALS INC's average Inv. to Assets has been 4.71%.
  • The median Inv. to Assets for RIGEL PHARMACEUTICALS INC during this period was 4.62%
  • RIGEL PHARMACEUTICALS INC reached its highest Inv. to Assets over the past 5 years at 9.21%.
  • The lowest Inv. to Assets recorded by RIGEL PHARMACEUTICALS INC in the same timeframe 1.48%

RIGEL PHARMACEUTICALS INC's Inv. to Assets vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Inv. to Assets Benchmarks
CompanyInv. to Assets
MRVI : MARAVAI LIFESCIENCES HOLDINGS INC 5.2%KROS : KEROS THERAPEUTICS INC 0%ARVN : ARVINAS INC 0%RGNX : REGENXBIO INC 0%VNDA : VANDA PHARMACEUTICALS INC 1.89%CTMX : CYTOMX THERAPEUTICS INC 0%XNCR : XENCOR INC 0%ESPR : ESPERION THERAPEUTICS INC 32.98%NKTR : NEKTAR THERAPEUTICS 0%PBYI : PUMA BIOTECHNOLOGY INC 4.41%

Definition of Inventory to Assets Ratio

[Calculation] [Inventory] as percentage of total [Assets], serves as an efficiency ratio - the lower the better.
Inventory / Assets
(=) Inv. to Assets
Inv. to Assets for RIGEL PHARMACEUTICALS INC is calculated as follows: Inventory [ $ 2.05M ] / Assets [ $ 123.06M ]
(=) Inv. to Assets [ 1.67% ]

RIGL - Inventory to Assets Ratio, Last 5 years

1.48%

Minimum

Dec 31, 2020

9.21%

Maximum

Jun 30, 2023

4.71%

Average

4.62%

Median

Inv. to Assets Benchmark Analysis

The chart above depicts the distribution of Inv. to Assets for companies in the Total Stock Market. The average Inv. to Assets of the companies is 6.09% with a standard deviation of 11.11%.
The following table provides additional summary stats:
Inv. to Assets in the Market:
filtered constituents4.46K
min0%
max98.39%
average6.09%
median0%
std11.11%